MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A

1,029
Loading...
Loading...
News
all
press releases
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q2 Loss, Lags Revenue Estimates
Maravai LifeSciences (MRVI) delivered earnings and revenue surprises of -33.33% and -2.23%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
More News
News Placeholder
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q1 Loss, Tops Revenue Estimates
Zacks·5mo ago
News Placeholder
MariMed Inc. (MRMD) Reports Q1 Loss, Lags Revenue Estimates
chainwire·6mo ago
News Placeholder
Securities Fraud Investigation Into Maravai LifeSciences Holdings, Inc. (MRVI) Announced Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Maravai LifeSciences Holdings, Inc. (Maravai or the...
Business Wire·8mo ago
News Placeholder
Maravai LifeSciences Securities Fraud Investigation: Investors Urged to Contact Award-Winning Firm, Gibbs Law Group LLP
Shares of Maravai LifeSciences Holdings, Inc. (Maravai LifeSciences) plunged over 21% in intraday trading on Tuesday, February 25, 2025, after the company disclosed it would be delaying its 2024...
Business Wire·8mo ago
News Placeholder
Maravai LifeSciences Holdings, Inc. (MRVI) Investors Who Lost Money Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Law Offices of Howard G. Smith announces an investigation on behalf of Maravai LifeSciences Holdings, Inc. (Maravai or the Company) (NASDAQ: MRVI) investors concerning the Companys possible...
Business Wire·8mo ago
News Placeholder
Securities Fraud Investigation Into Maravai LifeSciences Holdings, Inc. (MRVI) Announced Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz announces an investigation of Maravai LifeSciences Holdings, Inc. (Maravai or the Company) (NASDAQ: MRVI) on behalf of investors concerning the Companys possible...
Business Wire·8mo ago
News Placeholder
Maravai LifeSciences Completes Acquisition of the DNA and RNA Business of Officinae Bio
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today that it has completed its previously...
Business Wire·8mo ago
News Placeholder
TriLink BioTechnologies and Aldevron Enter into Non-exclusive License and Supply Agreement for CleanCap mRNA Capping Technology
TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has signed a non-exclusive License and Supply Agreement...
Business Wire·9mo ago
News Placeholder
TriLink BioTechnologies Partners with Avantor to Expand Nucleic Acid Solutions in Europe
TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has partnered with, Avantor, Inc. (NYSE: AVTR), a leading...
Business Wire·9mo ago

Latest MRVI News

View

Advertisement|Remove ads.

Advertisement|Remove ads.